Diabetics and families of diabetics should be aware that some types of diabetes medications can cause an increase health risk of pancreatic cancer. Many of these diabetes drugs are in the incretin mimetic class and may cause an increased health risk of pancreatic cancer and pancreatitis. These incretin diabetes drug include exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto). Some of these incretin diabetes drugs already include a black box warning regarding thyroid cancer risk, but evidence is growing that these drugs may also create an increased risk of pancreatic cancer.
People taking incretin diabetes drugs including: Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta, Oseni, and other diabetes drugs should be aware of the cancer health risks. Further, pancreatic cancer survivors and families of those killed by pancreatic cancer, should be aware that several lawsuits are currently pending against the drug companies for failing to warn diabetics of the dangers of pancreatic cancer while taking these drugs. It is also important to know that these pancreatic cancer diabetes drug lawsuits will have time limits regarding filing suit.
If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible. Please also feel free to go to the following web page for more information on Pancreatic Cancer Diabetes Drug Lawsuits.